FindTrial
Sign In

The effect of a Bhutanese Traditional Medicine “Yung-wa Zhi-thang” in reducing blood glucose in Type II diabetes patients

The effect of a Bhutanese Traditional Medicine “Yung-wa Zhi-thang” in reducing blood glucose and HbA1C levels in Type II diabetes patients: a prospective single-arm cohort study

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20180509002
Enrollment
122
Registered
2018-05-09
Start date
2018-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type II diabetes mellitus diabetes mellitus&#44

Interventions

Curcuma longa + Berberis aristata + Phyllanthus emblica + Tribulus terrestris
Experimental Drug
Yung&#45
wa Zhi&#45
thang

Sponsors

Department of Traditional Medicine Services (DTMS), Bhutan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Newly diagnosed as Type II diabetes; treatment naive. Normal Liver and Renal Function Tests at the start of the study.

Exclusion criteria

Exclusion criteria: Alcohol consumer and smokers; Patients with the history of taking antibiotics within two weeks prior to initiation of Yung-wa treatment

Design outcomes

Primary

MeasureTime frame
Change in fasting and post-prandial blood sugar, HbA1C level Fasting and post-prandial blood sugar at Month 0, 1, 2, 3, 4, 5, 6; HbA1C at Month 0, 3, 6 Fasting and post-prandial blood sugar, HbA1C—

Secondary

MeasureTime frame
Change in lipid profile Lipid profile at Month 0, 3, 6 Lipid profile—

Countries

Bhutan

Contacts

Public ContactTHINLEY DORJI

Jigme Dorji Wangchuck National Referral Hospital, Thimphu, Bhutan

dorji.thinleydr@gmail.com+97517997979

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026